Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE:002294)
59.13
+0.55 (0.94%)
Mar 18, 2026, 3:04 PM CST
93.49% (1Y)
| Market Cap | 65.92B +111.0% |
| Revenue (ttm) | 4.25B +8.8% |
| Net Income | 672.56M +10.1% |
| EPS | 0.60 +9.2% |
| Shares Out | 1.11B |
| PE Ratio | 98.51 |
| Forward PE | 98.22 |
| Dividend | 0.50 (0.85%) |
| Ex-Dividend Date | May 14, 2025 |
| Volume | 11,399,159 |
| Average Volume | 8,070,748 |
| Open | 52.47 |
| Previous Close | 58.58 |
| Day's Range | 52.47 - 59.98 |
| 52-Week Range | 29.78 - 65.63 |
| Beta | 0.48 |
| RSI | 68.52 |
| Earnings Date | Apr 21, 2026 |